Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
The board and senior managers are defined as insiders and are not allowed by law to buy or sell during the time between the end of the reporting period and the publication of the results. That's true of all listed companies. Have faith till the 27th, amuse yourselves with some smart sniper buying at bargain basement prices.
Very interesting move this one. The distributed ledger is what makes Bitcoin and other crypto-currencies work. More importantly, in the last year or so banks and major financial institutions like clearing houses have recognised that unless they adopt some of these operational innovations they could be sidelined by faster, low cost alternatives. EPOs move into this space is really quick. This is a big game changer if they manage it well.
Most of the business seems very small lots at the moment which suggests a lot of PI activity and no institutional buying. One of the jobs of the management of a small, growth company is to interest the institutions in stake-building for the longer term. That way the price doesn't get pushed around so much and we establish a decent base. Anyway, ten days to the interims - we can sweat these low levels for that long then hopefully a re-rating and wider recognition that OXB is a very decent prospect. If I hadn't already topped up at 8.6 I'd certainly be back in now!
I guess we have to wait till the interims on the 27th before OXB shifts out of the 8 level. I've been doing some quiet topping up trying to pick off some bargains but it's very frustrating seeing OXB knocking about these levels when I would have thought it was 10-12 even before the interims. Hopefully these will show the Novartis fees coming through in the first half which should beef up the P&L and make investors take notice. Might as well sit in the garden till then!
We're back at the top end of the 40-45p channel we've been in for so long - apart from that unexpected excursion down to 33. Given the recent news and the expansion plans it will be interesting to see if we can finally move back to a 50 target. Buying volumes not very high yet so I'm not expecting anything for a while but I have to think that >50 is more likely than <40 before year-end.
Good numbers from Man. Those performance related revenues are excellent. That should lead to an upturn in sales and a slowdown in redemptions. Back to 200+ maybe? (PS Daft headline from Ms Jain at Reuters. No way is 158 a record high!)
I agree this is a bit of a stretch for GVC but if it can be financed mainly by cheap debt we should be OK. GVC has a very good track record of taking over and assimilating, very quickly, other firms. Bwin is big but not indigestible. It's possible that the divvi payouts may indeed be disrupted slightly but I would imagine that if that becomes necessary the firm will explain what the longer term gains will be. I'm holding and looking for this to push to well over a fiver once the dust has settled.
I don't know what anyone else thinks but I thought this was a strong trading update. The increase in revenue, cash position and the strong pipeline are particularly promising. The geographical expansion suggests higher costs, which will have to be watched, but if the finals come out well then it may be that 2015-16 pushes us through break-even. Then we wait for a maiden divvi and we're away. Definitely a Hold in my view.
Not quite sure why there's a full 10 pc drop this afternoon on tiny volume since 410. Can this all be just because of a very speculative, unattributed piece in the Sunday Times saying GVC might re-bid for Bwin. Seems a bit harsh if it is. The BoD have a track record of shrewd purchases which become cash generative very quickly. Why the lack of faith this time!
I don't know about everyone else but it always smells a bit fishy to me when I see a sharp downdrop followed by big trading volume reports - often delayed - and a recovery in price levels. Is a broker/MM playing questionable games or is it just a happy coincidence that happens to suit the big buyer very well.
How does paying £900m for something with a market value of £800m produce a £100m profit?. Also, call me old-fashioned, but my Investing For Beginners experience suggests that when a firm like GVC produces a trading update which is strongly positive the SP should rise. Are existing holders so nervous that a) the possibility of a bidding war for BWIN and b) some as yet unknown activity downturn in Greece outweigh today's trading update. Makes no sense to me.
I agree Riv. That's a solid increase in output which should translate, if they done their housekeeping properly, into some good financial results. 22-23p is seriously low for this stock. Time for a topup methinks.
I wonder why EPO has gone so quiet? We had a head of European business and a head of global marketing appointed earlier five months ago since then nothing about sales, new contract wins etc. That was money well spent wasn't it! The interims were promising which is why I think EPO is a hold but the lack of newsflow is poor and I guess explains the drift below 40p. So come on Head of Global Marketing - inspire some global selling!
And the selling volumes are quite small, Doesn't seem as if major shareholders are worried at this point.
Today's reaction to the new numbers seem a bit overdone to me. Brammer's not the most exciting company in the world but it's in a growth industry, it's well diversified and on the surface seems responsibly managed. Anyone else got any thoughts?
Come on! This is the Daily Mail we're looking at. Hardly a sound basis for investment decision-making. But ALK is certainly cheap at these pricess and well worth supporting on fundamentals, prospects, sound management, good technology etc - all sorts of good reasons. Mystery to me why it came off its 40+ levels.
Excellent recovery today - back up to over 900 soon? But why is WKP's trading dominated by such tiny little lots?
I thought the results were pretty good too, certainly not enough to explain a drop from over 200 to below 170. Is somebody seeing something I'm not? What a shame - it's quite a big fly in my otherwise very profitable ointment today!